SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Trading Update

11 Nov 2025 07:00

RNS Number : 9552G
Forterra plc
11 November 2025
 

11 November 2025

FORTERRA PLC

 

Full year guidance maintained

 

Forterra plc, "the Group" a leading UK manufacturer of essential clay and concrete building products, provides this trading update for the ten-month period ended 31 October 2025.

 

Summary

 

·

YTD revenue of £336m, 16% ahead of the prior year (£290m)

·

New build housing demand remains stronger than the depressed RMI market

·

H2 despatches and revenue expected to be at similar levels to H1

·

Full year guidance maintained; H2 adjusted EBITDA expected to be modestly ahead of the H1 figure

 

Current Trading

 

Tougher prior year comparatives along with a recent moderation of demand from the run rates seen around the middle of the year have resulted in year on year revenue growth over the last four months reducing to 10% relative to the 20.4% reported in H1. New build housing continues to be our strongest market segment with RM&I remaining depressed. Accordingly, we continue to benefit from our greater exposure to extruded or wire cut bricks over soft mud.

 

Department for Business and Trade figures show that domestic brick despatches for the nine-month period to September 2025 were 10% ahead of the 2024 comparative, with our own brick market share continuing to recover toward longer term norms. Brick imports remain subdued, and whilst ahead of the prior year, remain flat as a percentage of overall consumption.

 

We continue to actively manage our production capacity with demand varying significantly by product type. Production continues to ramp up as planned at Desford, with both kilns now operational, increasing our output of extruded bricks and ensuring we continue to meet customer demand following a significant destocking during 2025. Elsewhere, we expect to continue managing output as we retain our discipline in matching production to demand.

 

Our financial position continues to strengthen and we anticipate that year-end net debt before leases will be below H1, with leverage a little above one times adjusted EBITDA on a banking covenant basis.

 

Strategic Progress

 

Construction at our Wilnecote factory is nearing completion, with commissioning underway and the first bricks expected to be produced ahead of the year end. Wilnecote will offer an enhanced range of bricks for the premium commercial and specification market, increasing our exposure to this attractive segment.

 

We have also made good progress in designing and commissioning the initial range of brick slips from our innovative Accrington facility with the initial range due to be launched shortly.

 

The previously announced closures of our Bison Bespoke and Formpave operations have been executed in accordance with our plans.

 

Outlook

 

We anticipate that H2 despatches and revenues will be at similar levels to H1. Consistent with our previous guidance, H2 adjusted EBITDA is expected to be modestly ahead of the H1 figure.

 

Whilst we remain mindful of the continued economic uncertainty and the impact it is having on current demand, the medium-term market fundamentals remain attractive with a shortage of housing, a strong desire within government to address this, and a constrained supply of essential building products. The Board remains confident that our recent investments in new production capacity leave the Group well placed to benefit from a future recovery of our markets.

 

ENQUIRIES

 

Forterra plc +44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

 

FTI Consulting +44 203 727 1340

Richard Mountain / Victoria Hayns

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBCBDBSGBDGUG
Date   Source Headline
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site
9th Aug 20219:32 amRNSHolding(s) in Company
3rd Aug 20212:49 pmRNSEmployee Benefit Trust Share Purchase
29th Jul 20217:56 amRNSProgressive publishes new research
29th Jul 20217:00 amRNSHalf-year Report
13th Jul 20216:03 pmRNSDirector/PDMR Shareholding
5th Jul 202111:22 amRNSEmployee Benefit Trust Share Purchase
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company
26th Jan 20218:15 amRNSProgressive publishes new research
26th Jan 20217:00 amRNSTrading Statement
6th Jan 20217:21 amRNSEmployee Benefit Trust Share Purchase
6th Jan 20217:21 amRNSDirector/PDMR Shareholding
4th Jan 20219:29 amRNSHolding(s) in Company
8th Dec 20202:28 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20201:00 pmRNSEmployee Benefit Trust Share Purchase
24th Nov 20208:24 amRNSProgressive publishes new research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.